Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BMD has over 30 years’ experience distributing and marketing high-level in vitro diagnostic products across Benelux. It specializes in niche markets with a focus on scientific expertise. Now part of Eurobio Group, it offers a broad portfolio including automation solutions for immunofluorescence (IFA), ELISA (EIA), chemiluminescence (CLIA), complement fixation tests (CFT), and more. Its product range covers autoimmunity testing, infectious serology, genetic disorders screening, oncology markers—including myeloma—and monitoring biotherapies. The company employs about 46 people with $5.4 million revenue reported recently.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomedical Diagnostics Manufacturing.